ArticleBMC infectious diseases2025
Investigation of Cryptosporidium spp. and Enterocytozoon bieneusi in free-ranged livestock on the southeastern Qinghai-Xizang Plateau, China.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prevalence and Molecular Characterisation of Cryptosporidium spp. and Giardia duodenalis in Equines in Algeria.Veterinary medicine and science · 2026Article
- Molecular Characterization and Zoonotic Potential ofTransboundary and emerging diseases · 2026Article
- Infections and genetic diversity of Cryptosporidium spp. and Giardia spp. in small wild mammals on the Eastern Tibetan plateau: public health implications.BMC microbiology · 2025Article
- Molecular Epidemiological Survey ofAnimals : an open access journal from MDPI · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundCryptosporidium spp. and Enterocytozoon bieneusi are zoonotic pathogens with global distribution, infecting humans and various livestock. For yaks, Tibetan sheep and horses, the traditional grazing models still hold a main position. After these animals become infected, it not only hinders the development of animal husbandry but also increases the risk of Cryptosporidium spp. and E. bieneusi transmission between livestock and herdsmen.
methodsIn the present study, a total of 750 fecal samples were collected from yaks, Tibetan sheep and horses in Shiqu County, Sichuan Province, from July to August 2023, and were analyzed by nested Polymerase chain reaction (PCR) amplification of the small subunit ribosomal RNA (SSU rRNA) gene of Cryptosporidium spp. and internal transcribed spacer (ITS) gene of E. bieneusi.
resultsThe prevalence of Cryptosporidium spp., and E. bieneusi were 2.1% (16/750) and 1.5% (11/750), respectively. Mixed infections of Cryptosporidium spp. and E. bieneusi were detected in two samples. Among these positive fecal samples, one Cryptosporidium species (Cryptosporidium suis) was identified in the yaks (n = 11), Tibetan sheep (n = 1), and horses (n = 4). Three E. bieneusi genotypes, including a known genotype BEB4 and two novel ones SQY1 and SQY2, were identified in the yaks (n = 7), while in Tibetan sheep (n = 4) only the known genotype BEB4 was detected. The novel genotype SQY1 was grouped into the human-pathogenic Group 1, and the known genotype BEB4 and the novel genotype SQY2 were grouped into Group 2. Enterocytozoon bieneusi was not detected in horses.
conclusionsCryptosporidium suis was identified in yaks and horses while zoonotic E. bieneusi genotype BEB4 in Tibetan sheep for the first time, expanding their host ranges. These findings suggested that yaks, Tibetan sheep and horses could act as potential sources of human Cryptosporidium spp. and E. bieneusi infections, implying that the presence of zoonotic species/genotypes could pose a threat to public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.